cholesterol
Terms related to the query
Term Similarity Weight in brain map N In query
parietal
0.001618853473202461
1.0
10159 In expansion
precuneus
0.0023385327475099527
0.8221398044918764
5186 In expansion
cingulate
0.0013906636409945835
0.5878438613663672
9501 In expansion
temporal
0.001669642620905555
0.5300608513642151
11897 In expansion
hippocampus
0.0007598926507056923
0.3803368169959933
4610 In expansion
prefrontal
0.0008524373368160887
0.24525828979825004
10017 In expansion
occipital
0.0005698338617936222
0.2383587187150337
6796 In expansion
medial temporal
0.0015956503753118845
0.2234518886144064
2289 In expansion
working
0.001653942819572838
0.21075096773330443
5201 In expansion
parahippocampal
0.0006502970678684923
0.1809256021096063
3512 In expansion
insula
0.0002576750749283752
0.15606709691017914
7050 In expansion
frontal
0.0006867611679498937
0.1398378948335851
11471 In expansion
memory
0.0025065169290841957
0.13972585232965515
8405 In expansion
working memory
0.001920608332362737
0.13287066968074668
4424 In expansion
matter
0.00044288987117565
0.0938370190850028
6324 In expansion
thalamus
0.00017751750376898042
0.08372762438736311
4891 In expansion
task
0.0007979182990654259
0.07854193482816263
12194 In expansion
white matter
0.0002909133456331796
0.0690693448402023
4236 In expansion
fusiform
0.00013902644380806343
0.0664280037381914
4278 In expansion
lobe
0.0016419116243290676
0.06439019442782473
7551 In expansion
cerebellum
0.0001166172175732706
0.0642886286312887
5578 In expansion
dementia
0.0067934776232666146
0.05459775124051849
1312 In expansion
pcc
0.0004394918996945521
0.04097744033629209
1595 In expansion
reward
0.00017205730978392885
0.037445497074730404
2823 In expansion
right
0.00048748766573103843
0.03047675340507841
13076 In expansion
left
0.00018986498574433534
0.02888534328803263
12782 In expansion
white
0.00012881974326318216
0.02340772087584815
6774 In expansion
auditory
4.143493565718253e-05
0.023064912399282825
4009 In expansion
default mode
0.00016437424891752706
0.019925695271392964
2555 In expansion
default
9.86582946681994e-05
0.019409589039531088
3687 In expansion
brainstem
4.1152668001041785e-05
0.016843208602844387
1502 In expansion
putamen
9.69447807138725e-05
0.01673443526724558
3208 In expansion
lingual
0.00018833426955383353
0.014113193760633854
2312 In expansion
visual
2.885543956973972e-05
0.013235981606662084
10448 In expansion
somatosensory
3.8757661535358186e-05
0.012740743375482434
2370 In expansion
ofc
8.948724796355918e-05
0.011992340476555558
1511 In expansion
motor
2.53271896817681e-05
0.01175783675473071
7928 In expansion
word
9.377976605428988e-05
0.011741121984654464
6479 In expansion
motion
2.6920123483035e-05
0.010224764803669427
9061 In expansion
superior
7.20313231276151e-05
0.009799751270579504
9978 In expansion
volume
0.002798098159670415
0.004740375925100153
9322 In expansion
performance
0.005084703017373395
0.0
9105 In expansion
mild
0.003078772513927124
0.0
1855 In expansion
metabolic
0.005368913905945871
0.0
2051 In expansion
taking
0.005316302125354963
0.0
4589 In expansion
risk
0.03670744465972964
0.0
3441 In expansion
risk taking
0.011590281234491679
0.0
304 In expansion
cognitive function
0.003973099059392591
0.0
2781 In expansion
cognitive impairment
0.004683200878311547
0.0
1209 In expansion
cognitive performance
0.0029510375801177287
0.0
1095 In expansion
cognitive decline
0.0039451118357839545
0.0
540 In expansion
cognitive
0.032936337885436304
0.0
11288 In expansion
cholesterol
1.0
0.0
106 In query
cognition
0.004147111102553042
0.0
4404 In expansion
clinical
0.0025604596732170136
0.0
7059 In expansion
disease
0.02420921264740655
0.0
5087 In expansion
decline
0.004211682321407231
0.0
1831 In expansion
csf
0.002929335736461771
0.0
1397 In expansion
alzheimer
0.05307334752867754
0.0
1345 In expansion
alzheimer disease
0.050023958218801
0.0
1238 In expansion
amyloid
0.007709346714333988
0.0
245 In expansion
associated
0.0025219185626849327
0.0
12814 In expansion
ad
0.05133621336115574
0.0
947 In expansion
aging
0.007894684085912337
0.0
1310 In expansion
atrophy
0.004069386047651944
0.0
1332 In expansion
brain
0.007786983590728584
0.0
13395 In expansion
carrier
0.010083659294213438
0.0
503 In expansion
biomarker
0.0029339295107622663
0.0
957 In expansion
high risk
0.00798989110379011
0.0
666 In expansion
high
0.0035790893540600262
0.0
12283 In expansion
healthy
0.002639000851154598
0.0
10760 In expansion
impairment
0.0036098681884470045
0.0
5107 In expansion
elderly
0.005245372824593543
0.0
790 In expansion
emission
0.003136136449843369
0.0
1987 In expansion
early
0.004556313016284521
0.0
6240 In expansion
genetic
0.005175370004482827
0.0
1704 In expansion
gm
0.007313674565765441
0.0
1092 In expansion
gm volume
0.002729873698742286
0.0
523 In expansion
group
0.0036859593490015017
0.0
12268 In expansion
Predicted distribution of activations in the literature
Download map
Publications related to the query
Current Serum Lipoprotein Levels and fMRI Response to Working Memory in Midlife
HIGHER SERUM TOTAL CHOLESTEROL LEVELS IN LATE MIDDLE AGE ARE ASSOCIATED WITH GLUCOSE HYPOMETABOLISM IN BRAIN REGIONS AFFECTED BY ALZHEIMER’S DISEASE AND NORMAL AGING
Multiple genetic imaging study of the association between cholesterol metabolism and brain functional alterations in individuals with risk factors for Alzheimer's disease
CHOLESTEROL-RELATED GENETIC RISK SCORES ARE ASSOCIATED WITH HYPOMETABOLISM IN ALZHEIMER’S-AFFECTED BRAIN REGIONS
Poorly controlled cholesterol is associated with cognitive impairment in T2DM: a resting-state fMRI study
Low HDL Cholesterol is Associated with Lower Gray Matter Volume in Cognitively Healthy Adults
Vascular health risks and fMRI activation during a memory task in older adults
Cardio-metabolic risk factors and cortical thickness in a neurologically healthy male population: Results from the psychological, social and biological determinants of ill health (pSoBid) study
ASSOCIATION BETWEEN GAB2 HAPLOTYPE AND HIGHER GLUCOSE METABOLISM IN ALZHEIMER'S DISEASE-AFFECTED BRAIN REGIONS IN COGNITIVELY NORMAL APOEε4 CARRIERS
How early can we predict Alzheimer's disease using computational anatomy?
Amyloid pathway-based candidate gene analysis of [11C]PiB-PET in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort
In vivoSPECT imaging of vesicular acetylcholine transporter using [123I]-IBVM in early Alzheimer's disease
A spatial covariance 123I-5IA-85380 SPECT study of α4β2 nicotinic receptors in Alzheimer's disease
Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer's disease
Evaluation of the screening power of Cognitive Abilities Screening Instrument for probable Alzheimer's disease using voxel-based morphometry
Specific white matter tissue microstructure changes associated with obesity
Alzheimer risk variant CLU and brain function during aging
Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease
Structural MRI changes detectable up to ten years before clinical Alzheimer's disease
Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance
Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer's disease risk groups
Residual vectors for Alzheimer disease diagnosis and prognostication
Application of calibrated fMRI in Alzheimer's disease
Comparison between brain CT and MRI for voxel-based morphometry of Alzheimer's disease
CATEGORICAL AND CORRELATIONAL ANALYSES OF BASELINE FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY IMAGES FROM THE ALZHEIMER’S DISEASE NEUROIMAGING INITIATIVE (ADNI)
Resting state FDG-PET functional connectivity as an early biomarker of Alzheimer's disease using conjoint univariate and independent component analyses
Neuropsychological profile of prodromal Alzheimer's disease (Prd-AD) and their radiological correlates
Fractional amplitude of low-frequency fluctuations is disrupted in Alzheimer’s disease with depression
The Influence of AD Family History and APOE4 on Mesial Temporal Lobe Activation
White matter diffusion alterations in normal women at risk of Alzheimer's disease